About Anapa Biotech
Anapa Biotech is a Healthcare company based in Hvidovre (Denmark) founded in 2002. Molecular tools to enhance the nucleic acids in PCR-based assays. Anapa Biotech has raised $1 million across 1 funding round from investors including Vecata. The company has 2 employees. Its chief executive, as recorded, is Soren Morgenthaler Echwald. Anapa Biotech offers products and services including MeltPlex® multiplex PCR and Nucleic Acid Assays. Its focus areas include Life Sciences, Genomics, Genomics Services and Genome Engineering. Its legal entity is ANAPA BIOTECH A/S.
Company details
Anapa Biotech was founded in 2002 in Hvidovre, Denmark, within the biotechnology sector. Proprietary Twisted Intercalating Nucleic Acid (TINA) molecules are developed to improve the thermal stability of duplex, triplex, and quadruplex helixes. These tools are applied in PCR-based assays and hybridization processes to support nucleic acid performance. Operations focus on molecular enhancements for research and diagnostic applications.
- Headquarters Hvidovre, Denmark
- Employees 2
- SectorsHealthcare
- Website anapabiotech.com
- Social LinkedIn
- Legal Name Anapa Biotech A/S
- Net Profit-$571.73 K (USD)-450as on Dec 31, 2019
- Total Equity Funding$1M (USD)
in 1 rounds
- Latest Funding Round$1M (USD), Series A
Jan 2007
- Investors
- Employee Count2
Products & Services of Anapa Biotech
Anapa Biotech offers a comprehensive portfolio of products and services, including MeltPlex® multiplex PCR and Nucleic Acid Assays.
Enables high throughput PCR for multiple diagnostic assays.
Supports advanced molecular testing in scientific and environmental fields.
Funding Insights of Anapa Biotech
Anapa Biotech has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Series A round of $1 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 1
- Last Round Series A — $1M
- First Round $1M
(Jan 2007)
- Investors Count 1
All 1 funding rounds of Anapa Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $1M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Anapa Biotech
Anapa Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Vecata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| vecata.com |
Investor details for Anapa Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Anapa Biotech
1 people are tracked at Anapa Biotech (1 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Soren Morgenthaler Echwald | Owner & CEO | Leadership |
Complete people profiles for Anapa Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Anapa Biotech
2 dated milestones of Anapa Biotech across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Anapa Biotech is founded.
- Funding First funding round of $1.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anapa Biotech
Anapa Biotech was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Anapa Biotech is headquartered in Hvidovre, Denmark.
Soren Morgenthaler Echwald is the CEO of Anapa Biotech, as recorded in our data.
Anapa Biotech is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Series A of $1M, raised on Jan 2007.
Anapa Biotech has 2 employees.
Anapa Biotech was founded in 2002 in Hvidovre, Denmark, within the biotechnology sector. Proprietary Twisted Intercalating Nucleic Acid (TINA) molecules are developed to improve the thermal stability of duplex, triplex, and quadruplex helixes. These tools are applied in PCR-based assays and hybridization processes to support nucleic acid performance. Operations focus on molecular enhancements for research and diagnostic applications.
Anapa Biotech offers MeltPlex® multiplex PCR and Nucleic Acid Assays.
Anapa Biotech has 1 investor. Key investors include Vecata.
Anapa Biotech operates through Anapa Biotech A/S.